文献速递功能神经外科神经重症

微血管减压术后不良事件:美国国家手术质量改进计划分析

Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis.
PubMed 文献 · World Neurosurg · 2019-05-11

基于美国国家手术质量改进计划(NSQIP)2006—2017年前瞻性登记数据,纳入1005例微血管减压术患者,分析30天不良事件与再入院预测因素。结果显示死亡率0.3%、主要神经并发症0.4%,ASA III-IV级和手术时长较长独立预测任何不良事件(9.2%)和住院时间延长,年龄不是预测因素;30天再入院率6.8%,最常见原因为手术部位感染(22.4%)和脑脊液漏(14.3%)。

要点

  • 微血管减压术后死亡率和主要神经并发症低,分别为0.3%和0.4%。
  • ASA III-IV级和手术时长较长独立预测任何不良事件及住院时间延长。
  • 30天再入院率6.8%,最常见原因为手术部位感染和脑脊液漏。

核心结论

  • 微血管减压术后发病率和死亡率低,患者年龄不是术后并发症的预测因素。
  • 较高ASA分级、糖尿病和较长手术时长预测任何不良事件和再入院。
  • ASA分级在风险分层上优于患者合并症总数或实验室值。

研究设计与样本

  • 回顾性分析美国国家手术质量改进计划(NSQIP)前瞻性登记库2006—2017年接受微血管减压术的患者。
  • 共纳入1005例患者,采用多因素logistic回归分析30天不良事件和计划外再入院的预测因素,多因素线性回归分析住院时间延长的预测因素。

主要发现

  • 1005例患者中,死亡率为0.3%,主要神经并发症率为0.4%,2.8%患者为非例行出院。
  • 任何不良事件发生率为9.2%,ASA III-IV级和较长手术时长是其独立预测因素(P ≤ 0.03),也预测住院时间延长。
  • 30天再入院率为6.8%,最常见原因为手术部位感染(22.4%)和脑脊液漏(14.3%)。
  • 较高ASA分级、糖尿病和手术时长是再入院的预测因素(P < 0.04)。
  • 患者年龄不是任何不良事件的预测因素。

临床怎么用

  • 术前可依据ASA分级、糖尿病和手术时长进行风险分层与患者咨询。
  • 关注手术部位感染和脑脊液漏以降低再入院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although microvascular decompression (MVD) is a durable treatment for medically refractory trigeminal neuralgia, hemifacial spasm, or glossopharyngeal neuralgia attributable to neurovascular conflict, few national studies have analyzed predictors of postoperative complications. OBJECTIVE: To determine the incidence and risk factors for adverse events after MVD. METHODS: Patients who underwent MVD were extracted from the prospectively collected National Surgical Quality Improvement Program registry (2006-2017). Multivariable logistic regression identified predictors of 30-day adverse events and unplanned readmission; multivariable linear regression analyzed predictors of a longer hospital stay. RESULTS: Among the 1005 patients evaluated, the mortality was 0.3%, major neurologic complication rate 0.4%, and 2.8% had a nonroutine hospital discharge. Patient age was not a predictor of any adverse events. Statistically significant independent predictors both of any adverse event (9.2%) and of a longer hospitalization were American Society of Anesthesiologists (ASA) classification III-IV designation and longer operative duration (P ≤ 0.03) The 30-day readmission rate was 6.8%, and the most common reasons were surgical site infections (22.4%) and cerebrospinal fluid leakage (14.3%). Higher ASA classification, diabetes mellitus, and operative time were predictors of readmission (P < 0.04). CONCLUSIONS: In this National Surgical Quality Improvement Program analysis, postoperative morbidity and mortality after MVD was low. Patient age was not a predictor of postoperative complications, whereas higher ASA classification, diabetes mellitus, and longer operative duration were predictive of any adverse event and readmission. ASA classification provided superior risk stratification compared with the total number of patient comorbidities or laboratory values. These data can assist with preoperative patient counseling and risk stratification.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cote DJ, Dasenbrock HH, Gormley WB, et al. Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis. World Neurosurg. 2019. PMID: 31082546. doi:10.1016/j.wneu.2019.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。